Cipla’s stock increased by 4% after its promoter family and Okasa Pharma sold their 2.52% stake via 3 block deals.
Share hike
The block deals included a total of 2.04 cr shares worth Rs 2,637 cr.
Block deal
This is not the first time that the promoter family has sold its stake, in 2020 also it sold 2.5% of its total stake in the open market. They had a total stake of 33.47%.
Not the first selloff
This stake offload is part of the succession part of the company. As per reports Blackstone, Baring Asia, and Torrent Pharma have tried to buy this stake in a non-binding offer but have not been successful.
Succession plan
Cipla’s shares made an intraday high of Rs. 1428.45 on Wednesday from the previous closing of Rs. 1357.35.